IRUXOL MONO Collagenase Ointment 1.2U
IRUXOL MONO Ointment is an advanced enzyme-based product specifically formulated for the enzymatic debridement of necrotising wounds. Its primary active component, collagenase, is designed to act selectively on collagen, effectively freeing the wound bed of necrotic material. By targeting and breaking down native collagen, the ointment creates a cleaner wound environment, which is intended to support and speed up the natural wound healing process. The design philosophy of IRUXOL MONO centers on selective action, ensuring that dead tissue is addressed while preserving healthy surrounding tissue. With a history spanning over two decades of successful use across various chronic wound types, including leg ulcers, diabetic ulcers, and pressure sores, it serves as a reliable option for clinical wound management. The product is intended to provide healthcare professionals with a gentle and effective tool for preparing wound beds to improve overall patient outcomes.
Размеры и технические характеристики
- Specifications
- Available on request
Производитель: Smith & Nephew plc · Источник данных: smith-nephew.com
Особенности изделия
Конструктивные характеристики согласно публикациям Smith+Nephew.
Selective Debridement
The ointment acts selectively on collagen to remove necrotic tissue without harming healthy tissue.
Enzymatic Formulation
Contains collagenase and protease enzymes to break down and clear dead tissue from the wound bed.
Proven Efficacy
Supported by over 20 years of successful use in managing a variety of chronic wound types.
Documentation
Official IFU, technique guides and full specifications are available on request through Azmed Devices.
Идентификация и технические характеристики изделия
Референсные идентификаторы для закупок, регистрации и тендерной документации.
| Производитель | Smith & Nephew plc |
|---|---|
| Бренд | Smith+Nephew |
| Семейство продукции | Современное лечение ран |
| Доступность по странам | Азербайджан |
Клиническое применение
IRUXOL MONO Collagenase Ointment 1.2U — это enzymatic ointment for necrotising wound debridement в семействе Современное лечение ран от Smith & Nephew plc, применяемый специалистами по интервенционным вмешательствам в процедурах, где показано использование enzymatic ointment for necrotising wound debridement данного класса.
Для получения полного перечня показаний к применению, противопоказаний и инструкции по применению (IFU) запросите официальную документацию Smith+Nephew через нашу клиническую команду. Azmed Devices поставляет IRUXOL MONO Collagenase Ointment 1.2U больницам и клиникам по всему Азербайджану.
Загрузки и документация
Инструкция по применению (IFU), технические спецификации и клиническая литература для IRUXOL MONO Collagenase Ointment 1.2U доступны по запросу у нашей клинической команды.
Запросить документациюЧасто задаваемые вопросы
- What types of wounds can be treated with IRUXOL MONO Ointment?
- It can be used to remove dead tissue from wounds such as leg ulcers, diabetic ulcers, and pressure sores.
- Are there any products that should not be used with this ointment?
- It should not be used with products that interfere with the medicine, such as antiseptics, certain antibiotics like tetracyclines, heavy metals, detergents, and soaps.
- How can our hospital order IRUXOL MONO Collagenase Ointment 1.2U in Azerbaijan?
- Contact Azmed Devices at info@azmeddevices.com. We provide manufacturer documentation, registration status and tender support, and coordinate supply directly with Smith+Nephew.
